{
    "code": 0,
    "data": [
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended on September 30 2025",
            "news_id": "22459a21-c458-4813-a21c-ef741aa32c05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0c4c856-770e-411d-a02b-99f047bc1988.pdf",
            "news_date": "2025-11-14 16:22:32",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 12 2025",
            "news_body": "Outcome of the Board meeting held on August 12 2025",
            "news_id": "ab3e037e-b32e-4cec-8833-f668f3e18d8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de7ad267-697d-4993-9a6d-a36203b72348.pdf",
            "news_date": "2025-08-12 16:35:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Year Ended On 31.03.2025",
            "news_body": "Financial Results year ended on 31.03.2025",
            "news_id": "0af10f60-d773-4721-8e62-6971529e5be3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb23b4e8-b561-4020-9894-d1e15ffee50a.pdf",
            "news_date": "2025-05-30 21:02:16",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 31.12.2024",
            "news_body": "Financial Results for the quarter ended on 31.12.2024.",
            "news_id": "904ed1c4-a636-410f-8db1-2887c49627e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4056b24a-a94d-4acb-bf2a-fd2723fbacfc.pdf",
            "news_date": "2025-02-11 15:53:02",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 14-11.2024",
            "news_body": "Outcome of the Board Meeting held on 14-11-2024",
            "news_id": "30c9496d-6f72-44fb-b01b-542788674023",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85b10326-d58f-4fac-9c68-bf9500f86a0b.pdf",
            "news_date": "2024-11-14 16:43:14",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 30.06.2024",
            "news_body": "Financial Results for the quarter ended on 30.06.2024",
            "news_id": "94b85a43-b71d-4f8b-aafa-04d792c7f09e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6524a73d-b235-42c1-81d0-e5a50cebe878.pdf",
            "news_date": "2024-08-13 15:18:44",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The FY 2024",
            "news_body": "Approval of Audited Financial results for the quarter & Year ended on 31.03.2024",
            "news_id": "e8cec1f1-04b6-4272-a2c2-4a3eb126179f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4408bdde-2f78-4f4a-9ea6-d04d396398f6.pdf",
            "news_date": "2024-05-29 16:39:36",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023",
            "news_body": "Unaudited Financial Results for the Quarter and Nine months ended on December 31, 2023",
            "news_id": "122a0ac7-0b75-4de4-aec6-3a14f6e6bb20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecebff43-8a38-4589-9da5-ed3f564bb082.pdf",
            "news_date": "2024-02-12 16:00:36",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results- Quarter And Half Year Ended September 30, 2023",
            "news_body": "Un-audited Financial Results- Quarter and half year ended September 30, 2023",
            "news_id": "e33a9f2b-0a6f-4022-ac6b-2b1391d0e4fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ee1c89d-1fbe-4bf9-8b2e-27389a843adb.pdf",
            "news_date": "2023-11-10 16:20:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On August 08, 2023",
            "news_body": "This is to inform you that the Board of Directors of the Company in its meeting held today i.e August 08, 2023, which commenced at 12.30 pm and concluded at 02.15 pm inter alia considered and approved the unaudited financial results of the company for the quarter ended on June 30, 2023.",
            "news_id": "2b3b29a3-2326-4b6a-884c-a65e7b679b48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41377633-cec2-4b2f-8336-57402c976618.pdf",
            "news_date": "2023-08-08 14:27:06",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Year Ended March 31, 2023",
            "news_body": "We wish to inform that the Board of Directors of the Company in its meeting held today i.e. May 29, 2023, which commenced at 02.30 p.m. and concluded at 04.00 p.m., inter alia, considered and approved the Audited Standalone & Consolidated Financial Results of the Company for year ended March 31, 2023 , further details attached.",
            "news_id": "2362ecaa-ffa5-4d56-bd22-7c5bec9eca91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=758dc12a-ed28-4d32-9563-3600d12f3601.pdf",
            "news_date": "2023-05-29 16:18:25",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Period Ended On 31St December 2022.",
            "news_body": "Financial Results For The Quarter And Nine Months Period Ended On 31st December 2022.",
            "news_id": "25d8a11f-86ee-4674-aa96-e32533bf8426",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c3afaae-1ebe-41e2-9cd3-401fbc413d65.pdf",
            "news_date": "2023-02-10 17:49:32",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Nine Months Period Ended On 31St December 2022.",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on December 31, 2022.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2022 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> c) An Investor Presentation of the company is enclosed as Annexure-C<BR> <BR> The meeting of the Board of Directors commenced on 02.30 p.m. and concluded at 03.30 p.m.<BR> <BR>",
            "news_id": "0f4af413-4793-411e-b7cf-ab135652d3e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c29ab401-d295-4a96-b841-ef15a4557842.pdf",
            "news_date": "2023-02-10 15:41:00",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on September 30, 2022.You are requested to take the same on record.",
            "news_id": "4b608136-ae88-44c4-ace6-6df02d022dbe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c91b7cb-5785-4b6f-b84b-9091a720d554.pdf",
            "news_date": "2022-11-23 14:11:59",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended On September 30, 2022",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2022.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on September 30, 2022 as Annexure-A and<BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> c) An Investor release on the financial results is enclosed as Annexure-C<BR> <BR> The meeting of the Board of Directors commenced on 02.30 p.m. and concluded at 03.30 p.m.",
            "news_id": "4be5002e-e379-41ae-83c6-441e965a25a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70e78eb5-18d2-4b20-8042-c3171c3ffea9.pdf",
            "news_date": "2022-11-11 15:41:34",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30, 2022",
            "news_body": "This is to inform that the Unaudited Standalone and Consolidated Financial Results of the Company for the<BR> quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today i.e. August 10, 2022. Further details attached.",
            "news_id": "b83287f8-2ad5-4b10-a949-bbaadd9cec74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06f6b84b-dba7-4af2-b670-5e98efb62197.pdf",
            "news_date": "2022-08-10 15:46:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on March 31, 2022.You are requested to take the same on record.",
            "news_id": "9e58b86e-0329-4eb4-aa75-c708fc3893e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfd49845-a968-430a-bec0-1790b4c95479.pdf",
            "news_date": "2022-06-07 12:23:11",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 25.05.2022",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2022.<BR> we enclose the following:<BR> <BR> a) Statement showing the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2022 as Annexure-A and<BR> b) Statutory Audit Report on the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2022 as Annexure-B<BR> c) An Investor release on the financial results is enclose as Annexure-C<BR> <BR> Further Board of Directors at their meeting held today recommended a final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2021-22.<BR> <BR> This is for your information and records.<BR>",
            "news_id": "d06854c8-0fe4-42aa-a9d3-b3667fad2ec4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4967ac31-211d-427b-944b-aae5e4a053c3.pdf",
            "news_date": "2022-05-25 16:23:05",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting. - Financial Results",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended on 31 December 2021.",
            "news_id": "7e2e807c-1928-4774-882d-bc78099aa56e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c2bfd07-5445-44dd-bab1-d5ff6e66210a.pdf",
            "news_date": "2022-02-08 15:51:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transaction",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "9e6f77d5-e102-4ff8-ac2f-2ee825984f25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff12db2e-9eec-4c72-8ef0-44e2d8d99cad.pdf",
            "news_date": "2021-11-08 11:49:08",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 03.11.2021",
            "news_body": "Outcome of the Board meeting held on 03.11.2021",
            "news_id": "00c33272-e4b2-4ea3-9074-e7be38a88281",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc5dccc3-f36d-40f1-9b7b-af1c54b11bc9.pdf",
            "news_date": "2021-11-03 14:56:13",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Financial Results For The Quarter Ended On June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on June 30, 2021 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> This is for your information and records.",
            "news_id": "6ca0cd1f-21ed-4eb5-a319-df7f95424d62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9f20ffa-554a-4470-9a37-104f48852f1c.pdf",
            "news_date": "2021-08-13 17:31:39",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on June 30, 2021 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> This is for your information and records.<BR>",
            "news_id": "41e61b96-d493-48bf-aecf-ba00d9ba7752",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea60eea1-e3b7-47a9-b340-de42b752111e.pdf",
            "news_date": "2021-08-13 16:13:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended On March 31, 2021.<BR> <BR>",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on March 31, 2021.<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "bb4385fa-945d-4c64-9fa5-e5f40266cc63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c9c7ccb-0c5f-4264-be09-73728de8dd3c.pdf",
            "news_date": "2021-06-26 16:10:33",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results For The Quarter / Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclose the following:<BR> a) Statement showing the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2021 as Annexure-A and<BR> b) Audit Report on the Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> Further Board of Directors at their meeting approved the following resolutions:<BR> c) Recommended a final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2020-21.<BR> d) Appointment of M/s SPB & Co as Cost Auditor of the Company for the FY 2021-22.<BR> e) Appointment of M/s Cheena & Associates as Internal Auditor of the Company for the FY 2021-22.<BR> f) Appointment of M/s AMJ & Associates as Secretarial Auditor of the Company for the FY 2021-22.<BR> g) Adoption of New Set of MOA and AOA of the Company as per Companies Act 2013, subject to approval of shareholders in the ensuing AGM.<BR> <BR>",
            "news_id": "46330074-2d59-41bf-b8f7-fa318fc1a7a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60d06ae-056f-47f0-9bc2-2b0dbb754826.pdf",
            "news_date": "2021-06-26 14:25:29",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Consolidated And Standalone Un-Audited Financial Results For The Quarter / Nine Months Ended December 31, 2020",
            "news_body": "Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a)   Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31.12.2020 duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company  <BR> <BR> b) Limited Review Report on the Un- Audited Financial Results (Standalone & Consolidated) <BR> <BR> c) The agreement dated 17.09.2019 which was entered between Medicamen Biotech Limited and Baxyran Healthcare Private Limited has been revoked, mutually decided by the parties and as a result Medicamen Biotech Limited shall remain 100% Shareholder of the Opal Pharmaceuticals Pty Ltd.<BR> <BR> d) Our state of art US FDA compliant Oncology Plant at Haridwar shall start taking plant validations of Oncology products from 24.02.2021.<BR> <BR> The meeting of the Board of Directors commenced at 02:00 p.m. and concluded at 03:15 p.m.<BR>",
            "news_id": "c46e9ac7-669b-47bd-8e33-6e37630552af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=447f41f7-5835-4760-997c-eb2c03978af8.pdf",
            "news_date": "2021-02-12 15:35:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}